Condensed Consolidated Balance Sheets (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Current assets
Cash and equivalents	$ 8,975	$ 5,901
Short-term investments	621	2,075
Accounts and other receivables, net	3,798	4,298
Inventories, net	1,172	1,091
Deferred income taxes	1,419	1,446
Prepaid expenses and other	558	543
Total current assets	16,543	15,354
Investments	123	119
Property and equipment, net	2,244	2,247
Intangible assets, net of amortization	1,993	2,323
Goodwill	6,199	6,130
Other assets	1,150	835
Total assets	28,252	27,008
Current liabilities
Short-term borrowings	411	1,020
Current maturities of long-term debt and lease obligations	23	22
Accounts payable and accrued liabilities	6,441	5,734
Total current liabilities	6,875	6,776
Long-term liabilities	3,425	2,239
Long-term debt and lease obligations	14,375	14,630
Commitments and contingencies
Equity
Net parent company investment in AbbVie Inc., prior to separation		3,713
Stockholders' equity
Common stock, issued 1,590,861,812 shares in 2013	16
Common stock held in treasury, 3,100,129 shares in 2013	(119)
Additional paid-in-capital	3,580
Retained earnings	1,081
Accumulated other comprehensive loss	(981)	(350)
Total stockholders' equity	3,577	(350)
Total equity	3,577	3,363
Total liabilities and equity	$ 28,252	$ 27,008